747422501	747422501	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
97122629	97122629	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5427156	5427156	CD	B-NP	O
|	|	CC	I-NP	O
5/20/2005	5/20/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
UPPER	UPPER	NNP	I-NP	I-protein
GI	GI	NNP	I-NP	O
BLEED	BLEED	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/7/2005	5/7/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/12/2005	6/12/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
UHAS	UHAS	NNP	B-NP	O
,	,	,	O	O
FRANKLYN	FRANKLYN	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Medicine	Medicine	NNP	I-NP	O
Ent	Ent	NNP	I-NP	O
Ster	Ster	NNP	I-NP	O
Villepeakechatdar	Villepeakechatdar	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Hematemesis	Hematemesis	NN	B-NP	O
.	.	.	O	O

PROBLEMS/DIAGNOSES	PROBLEMS/DIAGNOSES	NN	B-NP	O
CONSIDERED	CONSIDERED	VBD	B-VP	O
DURING	DURING	VBG	I-VP	O
THE	THE	DT	B-NP	O
HOSPITALIZATION	HOSPITALIZATION	NN	I-NP	O
:	:	:	O	O
Hematemesis	Hematemesis	NN	B-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
;	;	:	O	O
uncontrolled	uncontrolled	JJ	B-NP	O
,	,	,	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
NSAID	NSAID	NN	B-NP	O
abuse	abuse	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
supraventricular	supraventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hiatal	hiatal	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Barrett	Barrett	NNP	B-NP	O
's	's	POS	B-NP	O
esophagitis	esophagitis	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75-year-old	75-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	B-ADJP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	O	O
supraventricular	supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hiatal	hiatal	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
and	and	CC	O	O
esophageal	esophageal	JJ	B-NP	O
stricture	stricture	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
three	three	CD	B-NP	O
dilations	dilation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
remote	remote	JJ	I-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Tohall	Tohall	NNP	I-NP	O
Villeviewtrom	Villeviewtrom	NNP	I-NP	O
Moralb	Moralb	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
10/8/05	10/8/05	CD	B-NP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
UTI	UTI	NN	B-NP	B-protein
and	and	CC	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
NSAID	NSAID	NN	B-NP	O
abuse	abuse	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
low	low	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
experienced	experience	VBD	B-VP	O
mild	mild	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
emesis	emesis	NN	I-NP	O
that	that	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
progressed	progress	VBD	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
coffee-ground	coffee-ground	JJ	B-NP	O
emesis	emesis	NN	I-NP	O
without	without	IN	B-PP	O
melena	melena	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
orthostasis	orthostasis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
sick	sick	JJ	B-NP	O
contact	contact	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
roommate	roommate	NN	I-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
had	have	VBD	B-VP	O
gastroenteritis	gastroenteritis	NN	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
9/29/05	9/29/05	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Baview	Baview	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
And	And	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hematemesis	hematemesis	NN	I-NP	O
.	.	.	O	O

PERTINENT	PERTINENT	NNP	B-NP	O
REVIEW	REVIEW	NNP	I-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
orthostasis	orthostasis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
visual	visual	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
imbalance	imbalance	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
incontinence	incontinence	NN	I-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
frequency	frequency	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
urgency	urgency	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
NPH	NPH	NN	B-NP	B-protein
subcutaneously	subcutaneously	RB	B-NP	O
35	35	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
subcutaneously	subcutaneously	RB	B-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Reglan	Reglan	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
Spiriva	Spiriva	NNP	B-NP	O
18	18	CD	I-NP	O
mcg	mcg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
PhosLo	PhosLo	NNP	B-NP	O
667	667	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
200	200	CD	I-NP	O
mcg	mcg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
cream	cream	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
application	application	NN	I-NP	O
,	,	,	O	O
Actonel	Actonel	NNP	B-NP	O
35	35	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
,	,	,	O	O
Detrol	Detrol	NNP	B-NP	O
LA	LA	NNP	I-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
nifedipine	nifedipine	NN	B-NP	O
XL	XL	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
supraventricular	supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
causes	cause	VBZ	B-VP	O
rash	rash	NN	B-NP	O
,	,	,	O	O
ibuprofen	ibuprofen	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sulfa	sulfa	NN	B-NP	O
drugs	drug	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
cause	cause	VBP	B-VP	O
an	an	DT	B-NP	O
unknown	unknown	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
physical	physical	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
temperature	temperature	NN	B-NP	B-protein
96.2	96.2	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
87	87	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
146/90	146/90	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	B-protein
sat	sit	VBD	B-VP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
is	be	VBZ	B-VP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
general	general	JJ	I-NP	O
physical	physical	JJ	I-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
icterus	icterus	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
conjunctivae	conjunctivae	JJ	I-NP	O
pallor	pallor	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
occasional	occasional	JJ	B-NP	O
pauses	pause	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
good	good	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
abdomen	abdomen	NN	I-NP	O
,	,	,	O	O
normoactive	normoactive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
and	and	CC	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
exam	exam	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
showed	show	VBD	B-VP	O
pitting	pit	VBG	I-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
was	be	VBD	B-VP	O
nontender	nontender	JJ	B-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
good	good	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
strength	strength	NN	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
neurological	neurological	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
vomitus	vomitus	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
gastroccult	gastroccult	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Pertinent	Pertinent	JJ	B-NP	O
laboratory	laboratory	NN	I-NP	O
findings	finding	NNS	I-NP	O
showed	show	VBD	B-VP	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
140	140	CD	B-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
102	102	CD	B-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
of	of	IN	B-PP	O
19	19	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.6	2.6	CD	B-NP	O
,	,	,	O	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
max	max	NN	B-NP	O
of	of	IN	B-PP	O
over	over	IN	B-PP	O
6	6	CD	B-NP	O
,	,	,	O	O
anion	anion	NN	B-NP	O
gap	gap	NN	I-NP	O
19	19	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
on	on	IN	B-PP	O
chemistry	chemistry	NN	B-NP	O
351	351	CD	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
liver	liver	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
36.8	36.8	CD	B-NP	O
within	within	IN	B-PP	O
her	her	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
coags	coag	NNS	I-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
OR	OR	NN	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
PERFORMED	PERFORMED	VBD	B-VP	O
NOT	NOT	NN	B-NP	B-protein
IN	IN	NN	I-NP	I-protein
OR	OR	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
GI	GI	NN	I-NP	O
series	series	NN	I-NP	O
on	on	IN	B-PP	O
8/30/05	8/30/05	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
video	video	NN	I-NP	O
swallow	swallow	NN	I-NP	O
on	on	IN	B-PP	O
1/19/05	1/19/05	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
upper	upper	JJ	B-NP	O
endoscopy	endoscopy	NN	I-NP	O
on	on	IN	B-PP	O
11/6/05	11/6/05	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hematemesis	hematemesis	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
GI	GI	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
blood	blood	NN	I-NP	O
shown	show	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emesis	emesis	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Reglan	Reglan	NN	B-NP	O
,	,	,	O	O
initially	initially	RB	B-ADVP	O
IV	IV	CD	B-NP	O
than	than	IN	B-PP	O
p.o.	p.o.	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
gastroenteritis	gastroenteritis	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
sick	sick	JJ	B-NP	O
contacts	contact	NNS	I-NP	O
,	,	,	O	O
gastritis	gastritis	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
pervious	pervious	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
NSAID	NSAID	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
ulcer	ulcer	NN	B-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
esophageal	esophageal	JJ	I-NP	O
stricture	stricture	NN	I-NP	O
,	,	,	O	O
other	other	JJ	B-NP	O
enteritis	enteritis	NN	I-NP	O
or	or	CC	I-NP	O
DKA	DKA	NN	I-NP	O
given	give	VBN	B-VP	O
elevated	elevated	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
anion	anion	NN	B-NP	O
gap	gap	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
things	thing	NNS	I-NP	O
considered	consider	VBN	B-VP	O
were	be	VBD	B-VP	O
atypical	atypical	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hematemesis	hematemesis	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
the	the	DT	B-NP	O
barium	barium	NN	I-NP	O
swallow	swallow	NN	I-NP	O
on	on	IN	B-PP	O
8/30/05	8/30/05	CD	B-NP	O
.	.	.	O	O

Unfortunately	Unfortunately	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
canceled	cancel	VBN	I-VP	O
prematurely	prematurely	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
swallow	swallow	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
n.p.o.	n.p.o.	RB	B-ADVP	O
from	from	IN	B-PP	O
10/21/05	10/21/05	CD	B-NP	O
to	to	TO	B-PP	O
07	07	CD	B-NP	O
until	until	IN	B-SBAR	O
video	video	NN	B-NP	O
swallow	swallow	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
with	with	IN	B-PP	O
swallowing	swallow	VBG	B-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
with	with	IN	B-PP	O
chin	chin	NN	B-NP	O
tuck	tuck	NN	I-NP	O
maneuver	maneuver	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
initial	initial	JJ	I-NP	O
diet	diet	NN	I-NP	O
of	of	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
soft	soft	JJ	I-NP	O
with	with	IN	B-PP	O
liquids	liquid	NNS	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
with	with	IN	B-PP	O
advancement	advancement	NN	B-NP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Costine	Costine	NNP	I-NP	O
attending	attend	VBG	B-VP	O
,	,	,	O	O
and	and	CC	O	O
upper	upper	JJ	B-NP	O
endoscopy	endoscopy	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
11/6/05	11/6/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
nonerosive	nonerosive	JJ	B-NP	O
esophagitis	esophagitis	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
hiatal	hiatal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
known	know	VBN	B-VP	O
by	by	IN	B-PP	O
history	history	NN	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
stricture	stricture	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
emesis	emesis	NN	I-NP	O
subsided	subside	VBD	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
while	while	IN	B-SBAR	O
in-house	in-house	JJ	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Reglan	Reglan	NNP	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
and	and	CC	O	O
tolerated	tolerate	VBD	B-VP	O
regular	regular	JJ	B-NP	O
house	house	NN	I-NP	O
feeds	feed	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
emesis	emesis	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
an	an	DT	B-NP	O
aside	aside	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
diarrhea	diarrhea	NN	B-NP	O
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
pervious	pervious	JJ	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
use	use	NN	I-NP	O
for	for	IN	B-PP	O
UTI	UTI	NNP	B-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	B-cell_line
diff	diff	NNP	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
,	,	,	O	O
both	both	DT	O	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
suspicion	suspicion	NN	I-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Imodium	Imodium	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
had	have	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
through	through	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
after	after	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
slight	slight	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
reducing	reduce	VBG	B-VP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
supraventricular	supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
on	on	IN	B-PP	O
11/27/05	11/27/05	CD	B-NP	O
and	and	CC	I-NP	O
one	one	CD	I-NP	O
on	on	IN	B-PP	O
9/9/05	9/9/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
event	event	NN	I-NP	O
on	on	IN	B-PP	O
11/27/05	11/27/05	CD	B-NP	O
occurred	occur	VBD	B-VP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	RB	B-ADVP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
rates	rate	NNS	I-NP	O
in	in	IN	B-PP	O
200	200	CD	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
diltiazem	diltiazem	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
then	then	RB	B-ADVP	O
caused	cause	VBD	B-VP	O
reduction	reduction	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
.	.	.	O	O

Diltiazem	Diltiazem	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
9/9/05	9/9/05	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
a.m.	a.m.	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
160s	160	NNS	I-NP	B-DNA
,	,	,	O	O
again	again	RB	B-ADVP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
diltiazem	diltiazem	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
x1	x1	NN	I-NP	I-protein
and	and	CC	O	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
diltiazem	diltiazem	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
From	From	IN	B-PP	O
an	an	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
disease	disease	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
infections	infection	NNS	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
stool	stool	NN	B-NP	O
cultures	culture	NNS	I-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
status	status	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
an	an	DT	B-NP	O
endocrine	endocrine	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
was	be	VBD	B-VP	O
moderately	moderately	RB	I-VP	O
controlled	control	VBN	I-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
standing	standing	NN	I-NP	O
NPH	NPH	NN	I-NP	O
to	to	TO	B-PP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
while	while	IN	B-SBAR	O
n.p.o.	n.p.o.	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
low	low	JJ	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
initiating	initiate	VBG	B-VP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
initially	initially	RB	B-ADJP	O
uncontrolled	uncontrolled	JJ	I-ADJP	O
and	and	CC	O	O
aggressively	aggressively	RB	B-ADJP	O
managed	manage	VBN	I-ADJP	O
with	with	IN	B-PP	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
NPH	NPH	NN	I-NP	O
standing	standing	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
Ms.	Ms.	NNP	B-NP	O
Azen	Azen	NNP	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
72	72	CD	B-NP	O
,	,	,	O	O
range	range	NN	B-NP	O
68-93	68-93	CD	I-NP	O
,	,	,	O	O
normotensive	normotensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
120/50	120/50	CD	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
of	of	IN	B-PP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
and	and	CC	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
exams	exam	NNS	I-NP	O
were	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
benign	benign	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
loose	loose	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
notable	notable	JJ	B-ADJP	O
without	without	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
temperature	temperature	NN	B-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
90	90	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	I-ADVP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
inhaler	inhaler	IN	B-PP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
200	200	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Imodium	Imodium	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Spiriva	Spiriva	NNP	B-NP	O
18	18	CD	I-NP	O
mcg	mcg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Reglan	Reglan	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
KCl	KCl	NN	B-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
TP	TP	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

CONSULTANTS	CONSULTANTS	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
consultants	consultant	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
case	case	NN	I-NP	O
:	:	:	O	O
GI	GI	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Gornto	Gornto	NNP	I-NP	O
,	,	,	O	O
098-4680	098-4680	CD	B-NP	O
and	and	CC	O	O
Speech	Speech	NNP	B-NP	O
and	and	CC	O	O
Swallow	Swallow	NNP	B-NP	O
,	,	,	O	O
Clayton	Clayton	NNP	B-NP	O
Tattrie	Tattrie	NNP	I-NP	O
,	,	,	O	O
beeper	beeper	IN	B-PP	O
number	number	NN	B-NP	O
57221	57221	CD	I-NP	O
.	.	.	O	O

PENDING	PENDING	VBG	B-VP	O
TESTS	TESTS	NNS	B-NP	O
:	:	:	O	O
Clostridium	Clostridium	NN	B-NP	O
difficile	difficile	JJ	I-NP	O
stool	stool	NN	I-NP	O
culture	culture	NN	I-NP	O
.	.	.	O	O

FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
PLANS	PLANS	NNP	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Kid	Kid	NNP	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Samual	Samual	NNP	I-NP	O
Camus	Camus	NNP	I-NP	O
on	on	IN	B-PP	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
3/29/05	3/29/05	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
ADVANCE	ADVANCE	NNP	I-NP	O
DIRECTIVE	DIRECTIVE	NNP	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-8328468	2-8328468	CD	B-NP	O
EMS	EMS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LOVERA	LOVERA	NN	B-NP	O
,	,	,	O	O
TED	TED	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PLANCARTE	PLANCARTE	NNP	B-NP	O
,	,	,	O	O
FREDDIE	FREDDIE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5301263	5301263	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
6/22/05	6/22/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/22/05	6/22/05	CD	B-NP	O

